SELLAS Life Sciences (SLS) Other Accumulated Expenses (2011 - 2018)

SELLAS Life Sciences (SLS) has 5 years of Other Accumulated Expenses data on file, last reported at $1.3 million in Q1 2018.

• Other Accumulated Expenses for Q1 2018 came in at $1.3 million, up 36.84% year-over-year; the trailing twelve-month figure through Mar 2018 was $1.3 million (up 36.84% YoY), and the FY2017 annual result was $1.3 million, up 472.69% from the prior year.
• Other Accumulated Expenses steadied at $1.3 million in Q1 2018 per SLS's latest filing, from $1.3 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $25.0 million in Q4 2015 and troughed at $227000.0 in Q4 2016.
• A 4-year average of $4.6 million and a median of $1.3 million in 2017 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2016 and 2017: Other Accumulated Expenses slumped 99.09% in 2016, then soared 472.69% in 2017.
• A 4-year view of Other Accumulated Expenses shows it stood at $25.0 million in 2015, then tumbled by 99.09% to $227000.0 in 2016, then soared by 472.69% to $1.3 million in 2017, then changed by 0.0% to $1.3 million in 2018.
• Business Quant data shows SLS's Other Accumulated Expenses at $1.3 million in Q1 2018, $1.3 million in Q4 2017, and $1.3 million in Q3 2017.